These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 20596658

  • 1. Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells.
    Zheng X, Cui D, Xu S, Brabant G, Derwahl M.
    Int J Oncol; 2010 Aug; 37(2):307-15. PubMed ID: 20596658
    [Abstract] [Full Text] [Related]

  • 2. Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines.
    Lopez JP, Wang-Rodriguez J, Chang C, Chen JS, Pardo FS, Aguilera J, Ongkeko WM.
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1022-7. PubMed ID: 17938326
    [Abstract] [Full Text] [Related]

  • 3. Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2.
    Carina V, Zito G, Pizzolanti G, Richiusa P, Criscimanna A, Rodolico V, Tomasello L, Pitrone M, Arancio W, Giordano C.
    Thyroid; 2013 Jul; 23(7):829-37. PubMed ID: 23301671
    [Abstract] [Full Text] [Related]

  • 4. Preliminary study of the effects of β-elemene on MCF-7/ADM breast cancer stem cells.
    Dong Y, Li L, Wang L, Zhou T, Liu JW, Gao YJ.
    Genet Mol Res; 2015 Mar 27; 14(1):2347-55. PubMed ID: 25867381
    [Abstract] [Full Text] [Related]

  • 5. Synergistic anti-proliferative effect of metformin and sorafenib on growth of anaplastic thyroid cancer cells and their stem cells.
    Chen G, Nicula D, Renko K, Derwahl M.
    Oncol Rep; 2015 Apr 27; 33(4):1994-2000. PubMed ID: 25683253
    [Abstract] [Full Text] [Related]

  • 6. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
    Alberti L, Losi L, Leyvraz S, Benhattar J.
    PLoS One; 2015 Apr 27; 10(7):e0132977. PubMed ID: 26185996
    [Abstract] [Full Text] [Related]

  • 7. Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents.
    Chen G, Xu S, Renko K, Derwahl M.
    J Clin Endocrinol Metab; 2012 Apr 27; 97(4):E510-20. PubMed ID: 22278418
    [Abstract] [Full Text] [Related]

  • 8. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells.
    Jia Q, Zhang X, Deng T, Gao J.
    Cell Reprogram; 2013 Apr 27; 15(2):143-50. PubMed ID: 23438193
    [Abstract] [Full Text] [Related]

  • 9. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
    Lee SI, Kim DK, Seo EJ, Choi EJ, Kwon YW, Jang IH, Lee JC, Kim HY, Shong M, Kim JH, Kim SJ.
    Thyroid; 2017 Nov 27; 27(11):1424-1432. PubMed ID: 28920531
    [Abstract] [Full Text] [Related]

  • 10. In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines.
    Zito G, Richiusa P, Bommarito A, Carissimi E, Russo L, Coppola A, Zerilli M, Rodolico V, Criscimanna A, Amato M, Pizzolanti G, Galluzzo A, Giordano C.
    PLoS One; 2008 Nov 27; 3(10):e3544. PubMed ID: 18958156
    [Abstract] [Full Text] [Related]

  • 11. Ultrasound reverses chemoresistance in breast cancer stem cell like cells by altering ABCG2 expression.
    Guo L, Zheng P, Fan H, Wang H, Xu W, Zhou W.
    Biosci Rep; 2017 Dec 22; 37(6):. PubMed ID: 28935760
    [Abstract] [Full Text] [Related]

  • 12. ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer.
    Xie ZY, Lv K, Xiong Y, Guo WH.
    Oncol Res Treat; 2014 Dec 22; 37(11):666-8, 670-2. PubMed ID: 25427584
    [Abstract] [Full Text] [Related]

  • 13. Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma.
    Haghpanah V, Fallah P, Naderi M, Tavakoli R, Soleimani M, Larijani B.
    Life Sci; 2016 Feb 01; 146():34-9. PubMed ID: 26772823
    [Abstract] [Full Text] [Related]

  • 14. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
    Hu J, Zhang X, Wang F, Wang X, Yang K, Xu M, To KK, Li Q, Fu L.
    Oncotarget; 2015 Dec 29; 6(42):44643-59. PubMed ID: 26556876
    [Abstract] [Full Text] [Related]

  • 15. Functional characteristics of cancer stem cells and their role in drug resistance of prostate cancer.
    Castillo V, Valenzuela R, Huidobro C, Contreras HR, Castellon EA.
    Int J Oncol; 2014 Sep 29; 45(3):985-94. PubMed ID: 24990514
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL, Overman MJ, Petrofski JA, Campbell PA, de Marzo AM, Nelson WG.
    Int J Oncol; 2000 Dec 29; 17(6):1077-86. PubMed ID: 11078791
    [Abstract] [Full Text] [Related]

  • 18. Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia.
    To KK, Poon DC, Wei Y, Wang F, Lin G, Fu LW.
    Biochem Pharmacol; 2015 Sep 01; 97(1):27-37. PubMed ID: 26206183
    [Abstract] [Full Text] [Related]

  • 19. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1).
    Mato E, González C, Moral A, Pérez JI, Bell O, Lerma E, de Leiva A.
    J Mol Endocrinol; 2014 Jun 01; 52(3):289-300. PubMed ID: 24643400
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.